ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/2/2021ACC: 0001209191-21-067649
Officer· Interim CFO
Since Jun 2021
+4.19K
Net shares
Net buyer
$3.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.19K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.19K
Price / share
$0.88
Trade value
$3.67K
% of position
5.0%
11/30/2021
83.35K→87.53K
Total
Net shares
+4.19K
Net value
$3.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2021 | A · Award | +4.19K | $0.88 | $3.67K | 5.0% | 83.35K | 87.53K |
| Total | +4.19K | $3.67K | ||||||
Derivative Transactions0
No derivative transactions reported